Key facts
- This page summarizes Bette Jacobs's Form 4 filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2023, 21:51.
Bette Jacobs - 13 Dec 2023 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- Reporting relationship
- Director
- Issuer ticker
- SHPH
- Reported as of
- 13 Dec 2023
- Net transaction value
- -$1,926
- SEC form
- 4
- Accepted by SEC
- 20 Dec 2023, 21:51:28 UTC
- Prior SEC filing
- 03 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bette Jacobs
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Bette Jacobs filed Form 4 for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) on 20 Dec 2023.
Change
- Previous filing in this sequence was filed on 03 Jan 2023.
- Current net transaction value: -$1,926.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SHPH
transaction
Common Stock
Sale
- Transaction value
- $1,926
- Shares
- -4,157
- Change %
- -13%
- Price
- $0.4632
- Shares after
- 27,064
- Date
- 13 Dec 2023
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
Footnote F2
Consists of (i) 15,201 shares of common stock and (ii) 11,863 RSUs which remain subject to certain vesting conditions.